- Home
- TANH vs CERO Comparison
TANH vs CERO Comparison
Compare TANH & CERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TANH
- CERO
- Stock Information
- Founded
- TANH 2001
- CERO 2017
- Country
- TANH China
- CERO United States
- Employees
- TANH N/A
- CERO N/A
- Industry
- TANH
- CERO
- Sector
- TANH
- CERO
- Exchange
- TANH Nasdaq
- CERO Nasdaq
- Market Cap
- TANH 3.5M
- CERO 3.5M
- IPO Year
- TANH 2015
- CERO N/A
- Fundamental
- Price
- TANH $2.00
- CERO $9.93
- Analyst Decision
- TANH
- CERO Strong Buy
- Analyst Count
- TANH 0
- CERO 2
- Target Price
- TANH N/A
- CERO $45.00
- AVG Volume (30 Days)
- TANH 33.3K
- CERO 3.3M
- Earning Date
- TANH 07-07-2025
- CERO 08-13-2025
- Dividend Yield
- TANH N/A
- CERO N/A
- EPS Growth
- TANH N/A
- CERO N/A
- EPS
- TANH N/A
- CERO N/A
- Revenue
- TANH $42,940,136.00
- CERO N/A
- Revenue This Year
- TANH N/A
- CERO N/A
- Revenue Next Year
- TANH N/A
- CERO N/A
- P/E Ratio
- TANH N/A
- CERO N/A
- Revenue Growth
- TANH N/A
- CERO N/A
- 52 Week Low
- TANH $1.45
- CERO $6.71
- 52 Week High
- TANH $38.40
- CERO $895.40
- Technical
- Relative Strength Index (RSI)
- TANH 45.28
- CERO 50.09
- Support Level
- TANH $1.95
- CERO $8.12
- Resistance Level
- TANH $2.14
- CERO $13.14
- Average True Range (ATR)
- TANH 0.14
- CERO 2.83
- MACD
- TANH -0.01
- CERO 0.39
- Stochastic Oscillator
- TANH 21.21
- CERO 19.58
About TANH Tantech Holdings Ltd.
Tantech Holdings Ltd manufactures bamboo charcoal-based products. The company through its subsidiaries is engaged in the production and distribution of household products along with a trading business which involves the export of charcoal products. It also manufactures electric double-layer capacitors carbon materials and low-emission barbecue charcoal. Its product portfolio includes air purifiers and humidifiers, underfloor humidity control, pillows and mattresses, wardrobe deodorizers, mousepads, and wrist mats, refrigerator deodorant, and charcoal toilet cleaner disks. The company has two reportable segments; the Consumer Product segment, and the Electric Vehicle (EV) segment.
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.